Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.94%
+21.47%
+3.35%
+1.19%
-0.30%
IOT
Samsara Inc.
$37.21
Strengths
Outperform the market
Earnings are forecast to grow
Chart
$36.94 (+0.73%)
$39.24 (-5.17%)
$46.54 (-20.05%)
$50.26 (-25.96%)
IOT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
IOT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue increase YoY
Eps growth
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Outperform the market
Earnings are forecast to grow
IOT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
IOT Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
IOT Earnings
The TTM reflects 12-month period, providing review of IOT financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is IOT current stock price?
What are IOT stock strengths?
What risks are associated with IOT stock?
When is IOT next earnings report?
What is IOT market cap and volume?
What is IOT's current Stock IQ?
Should I buy IOT stock right now?
Is IOT a Strong Buy right now?
What does a 'Strong Buy' rating mean for IOT?
What does a 'Strong Sell' rating mean for IOT?
What factors influence IOT's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.94%
+21.47%
+3.35%
+1.19%
-0.30%
IOT
Samsara Inc.
Current Price
$37.21
Stock Insights
Strengths
Outperform the market
Earnings are forecast to grow
Chart
$36.94 (+0.73%)
$39.24 (-5.17%)
$46.54 (-20.05%)
$50.26 (-25.96%)
IOT Analysts Opinion
IOT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue increase YoY
Eps growth
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Outperform the market
Earnings are forecast to grow
IOT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
IOT Street view is bullish and have positive views on the near-term outlook
IOT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
IOT Earnings
The TTM data reflects the most recent 12-month period, providing overview of IOT financial performance.
IOT Financial Health
The company financial health has moderately improved over the past year
Financial Score
IOT Latest Analysis
Samsara Inc. (IOT) Laps the Stock Market: Heres Why. In the closing of the recent trading day Samsara Inc. (IOT) stood at $37.21 denoting a 1.83% move from the preceding trading day.
Today
RANI: Chugai Deal Announced. By With investors perched on the edge of their seats for months Rani Therapeutics Holdings Inc. (NASDAQ:RANI) announces a deal including upfront milestones and partner-funded asset development. On October 18th Rani and Chugai Pharmaceutical disclosed a collaboration and license agreement that includes a $10 million upfront payment the potential for $75 million in technology transfer and development milestones $100 million in sales milestones and single digit royaltie
Today
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing. Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones up to $100 million in sales milestones and single digit royalties on product sales for the first license agreementCh
Fri Oct 17, 2025
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules. Financing led by Samsara BioCapital L.P. (Samsara) with participation from additional investors including RA Capital Management Anomaly Special Situations Funds Invus and Mr. Mir ImranAt the closing of the financing each of Samsara and Anomaly will have the right to designate one member of the Company'.s board of directors ) a clinical-stage biotherapeutics company focused on t
Fri Oct 17, 2025
Samsara Inc. (IOT) Laps the Stock Market: Heres Why. Samsara Inc. (IOT) closed at $37.56 in the latest trading session marking a 1.9% move from the prior day.
Mon Oct 13, 2025
Excellergy Debuts with $70 Million Series A Financing to Advance First-in-Class Portfolio of Trifunctional Effector Cell Response Inhibitors (ECRIs) for Complete Allergic Control. -Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy rapid relief and complete control of allergic responses by targeting the effector cell --Series A Financing Provided by Samsara BioCapital Red Tree Venture Capital and Decheng Capital --Industry Veteran Todd Zavodn
Mon Oct 13, 2025
Samsara: Long-Term Growth Story De-Risked.
Tue Sep 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.